() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Cannabinoid

Blissco Selected to Present at Sick Kids Hospital on Canadian Childhood Cannabinoid Clinical Trials

Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia and a licensed processor, producer, and distributor of premium dried cannabis and cannabis oil. The Company is pleased to announce that it has been invited to present at the Canadian Childhood Cannabinoid Clinical Trials (C4T) Workshop at Sick Kids Hospital in Toronto on February 27 and 28.
Read more

1933 Industries Signs on Pro MMA Fighter Sarah Moras to Promote Canna HempX and its New Action Sports Division

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX: TGIFF), a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness products, is pleased to announce that it has engaged professional athlete and mixed martial arts fighter ("MMA"), Ms. Sarah Moras, as a Canna Hemp™ sponsored athlete for a six-month engagement,  promoting the Company's Action Sports Division and representing the Canna HempX™ brand.
Read more

FSD Pharma and SciCann Therapeutics to present at the iCDP Summit in Boston

FSD Pharma Inc. ("FSD Pharma") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that Dr. Zohar Koren, CEO of its Strategic Partner SciCann Therapeutics ("SciCann") and Head of its Scientific Advisory Board, will present at the International Cannabinoid-Derived Pharmaceuticals Summit ("iCDP Summit") in Boston, on December 11-12, 2018.
Read more